SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-058066
Filing Date
2022-09-22
Accepted
2022-09-22 17:19:45
Documents
17
Period of Report
2022-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea166170-8k_relmadather.htm   iXBRL 8-K 32889
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION ea166170ex3-1_relmadather.htm EX-3.1 1322
3 FORM OF EXCHANGE WARRANT ea166170ex4-1_relmadather.htm EX-4.1 72316
4 EXCHANGE AGREEMENT BETWEEN RELMADA THERAPEUTICS, INC., AND VENROCK HEALTHCARE CA ea166170ex10-1_relmadather.htm EX-10.1 40090
5 GRAPHIC ex3-1_001.jpg GRAPHIC 251999
6 GRAPHIC ex3-1_002.jpg GRAPHIC 199636
  Complete submission text file 0001213900-22-058066.txt   971189

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rlmd-20220921.xsd EX-101.SCH 3224
8 XBRL LABEL FILE rlmd-20220921_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE rlmd-20220921_pre.xml EX-101.PRE 22357
11 EXTRACTED XBRL INSTANCE DOCUMENT ea166170-8k_relmadather_htm.xml XML 3727
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 221260078
SIC: 2834 Pharmaceutical Preparations